Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
Contact

Press Releases

Year

May 5, 2022

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results

April 1, 2022

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting

March 23, 2022

Longboard Pharmaceuticals to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit

March 22, 2022

Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference

March 21, 2022

Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer

March 3, 2022

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

January 5, 2022

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 17 of 17

©2022 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
Contact